| ONCY Stock | | | USD 0.93 0.02 2.11% |
Oncolytics Biotech financial indicator trend analysis is much more than just breaking down Oncolytics Biotech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncolytics Biotech is a good investment. Please check the relationship between Oncolytics Biotech Net Income From Continuing Ops and its Other Operating Expenses accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
For more information on how to buy Oncolytics Stock please use our
How to Invest in Oncolytics Biotech guide.
Net Income From Continuing Ops vs Other Operating Expenses
Net Income From Continuing Ops vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Oncolytics Biotech Net Income From Continuing Ops account and
Other Operating Expenses. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Oncolytics Biotech's Net Income From Continuing Ops and Other Operating Expenses is -0.2. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Oncolytics Biotech, assuming nothing else is changed. The correlation between historical values of Oncolytics Biotech's Net Income From Continuing Ops and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Oncolytics Biotech are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Net Income From Continuing Ops i.e., Oncolytics Biotech's Net Income From Continuing Ops and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | -0.2 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Net Income From Continuing Ops
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Oncolytics Biotech. It is also known as Oncolytics Biotech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Oncolytics Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncolytics Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
For more information on how to buy Oncolytics Stock please use our
How to Invest in Oncolytics Biotech guide.At this time, Oncolytics Biotech's
Selling General Administrative is fairly stable compared to the past year.
Enterprise Value is likely to rise to about 118
M in 2024, whereas
Tax Provision is likely to drop slightly above 84.1
K in 2024.
Oncolytics Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Oncolytics Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Oncolytics Biotech fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Oncolytics Stock Analysis
When running Oncolytics Biotech's price analysis, check to
measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to
predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.